Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
Nat Med
    August 2022
  1. GILBERT PB, Huang Y, deCamp AC, Karuna S, et al
    Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
    Nat Med. 2022 Aug 22. pii: 10.1038/s41591-022-01953.
    >> Share

  2. DE BAETSELIER I, Van Dijck C, Kenyon C, Coppens J, et al
    Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium.
    Nat Med. 2022 Aug 12. pii: 10.1038/s41591-022-02004.
    >> Share

    July 2022
    Long-acting agents for HIV treatment and prevention.
    Nat Med. 2022 Jul 22. pii: 10.1038/s41591-022-01917.
    >> Share

    June 2022
  4. TEGALLY H, Moir M, Everatt J, Giovanetti M, et al
    Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.
    Nat Med. 2022 Jun 27. pii: 10.1038/s41591-022-01911.
    >> Share

    May 2022
  5. JULG B, Stephenson KE, Wagh K, Tan SC, et al
    Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
    Nat Med. 2022 May 12. pii: 10.1038/s41591-022-01815.
    >> Share

    April 2022
  6. CASAZZA JP, Cale EM, Narpala S, Yamshchikov GV, et al
    Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
    Nat Med. 2022 Apr 11. pii: 10.1038/s41591-022-01762.
    >> Share

    March 2022
  7. ARSENAULT C, Gage A, Kim MK, Kapoor NR, et al
    COVID-19 and resilience of healthcare systems in ten countries.
    Nat Med. 2022 Mar 14. pii: 10.1038/s41591-022-01750.
    >> Share

    February 2022
  8. O'LEARY K
    HIV variant causes concern.
    Nat Med. 2022 Feb 14. pii: 10.1038/d41591-022-00034.
    >> Share

    January 2022
  9. MILLER JS, Davis ZB, Helgeson E, Reilly C, et al
    Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial.
    Nat Med. 2022 Jan 31. pii: 10.1038/s41591-021-01651.
    >> Share

  10. O'LEARY K
    HIV and skin cancer risk.
    Nat Med. 2022 Jan 6. pii: 10.1038/d41591-022-00001.
    >> Share

    December 2021

  11. Vaccine development needs a boost.
    Nat Med. 2021 Dec 2. pii: 10.1038/s41591-021-01633.
    >> Share

  12. DEEKS SG, Archin N, Cannon P, Collins S, et al
    Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.
    Nat Med. 2021 Dec 1. pii: 10.1038/s41591-021-01590.
    >> Share

  13. MORRIS L
    mRNA vaccines offer hope for HIV.
    Nat Med. 2021;27:2082-2084.
    >> Share

  14. ZHANG P, Narayanan E, Liu Q, Tsybovsky Y, et al
    A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.
    Nat Med. 2021;27:2234-2245.
    >> Share

    November 2021
  15. TANG P, Hasan MR, Chemaitelly H, Yassine HM, et al
    BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
    Nat Med. 2021 Nov 2. pii: 10.1038/s41591-021-01583.
    >> Share

    October 2021
  16. BLAZKOVA J, Gao F, Marichannegowda MH, Justement JS, et al
    Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy.
    Nat Med. 2021 Oct 28. pii: 10.1038/s41591-021-01503.
    >> Share

  17. STEPHENSON KE, Julg B, Tan CS, Zash R, et al
    Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
    Nat Med. 2021 Oct 7. pii: 10.1038/s41591-021-01509.
    >> Share

  18. MATTHEWS RP, Patel M, Barrett SE, Haspeslagh L, et al
    Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial.
    Nat Med. 2021 Oct 4. pii: 10.1038/s41591-021-01479.
    >> Share

    September 2021
  19. ZHANG F, Karamagi H, Nsenga N, Nanyunja M, et al
    Predictors of COVID-19 epidemics in countries of the World Health Organization African Region.
    Nat Med. 2021 Sep 3. pii: 10.1038/s41591-021-01491.
    >> Share

    July 2021
  20. CHEMAITELLY H, Yassine HM, Benslimane FM, Al Khatib HA, et al
    mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
    Nat Med. 2021 Jul 9. pii: 10.1038/s41591-021-01446.
    >> Share

    June 2021
  21. TURBE V, Herbst C, Mngomezulu T, Meshkinfamfard S, et al
    Deep learning of HIV field-based rapid tests.
    Nat Med. 2021 Jun 17. pii: 10.1038/s41591-021-01384.
    >> Share

  22. DHARAN NJ, Yeh P, Bloch M, Yeung MM, et al
    HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.
    Nat Med. 2021 Jun 7. pii: 10.1038/s41591-021-01357.
    >> Share

    March 2021
  23. PLANAS D, Bruel T, Grzelak L, Guivel-Benhassine F, et al
    Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
    Nat Med. 2021 Mar 26. pii: 10.1038/s41591-021-01318.
    >> Share

    November 2020
  24. EDRIDGE AWD, Kaczorowska J, Hoste ACR, Bakker M, et al
    Seasonal coronavirus protective immunity is short-lasting.
    Nat Med. 2020;26:1691-1693.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016